From the ∗Institute of Medical Science, University of Toronto
†Molecular Brain Science Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health
‡Department of Psychiatry, University of Toronto
§Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health
∥Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health
¶Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Received August 16, 2019; accepted after revision January 1, 2020.
Reprints: James L. Kennedy, MD, FRSC, Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, CAMH 250 College Street, M5T 1R8, Toronto, ON, Canada (e-mail: [email protected]); or Clement Zai, PhD, Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, CAMH 250 College Street, M5T 1R8, Toronto, ON, Canada (e-mail: [email protected]).
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).
C.C.Z. and J.L.K. are co-senior authors.
